Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and Ventricular Dysfunction

angiotensin ii, des-phe(8)- has been researched along with Ventricular Dysfunction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castro, P; Collantes, P; Copaja, M; Diaz-Araya, G; Godoy, I; Jalil, JE; Lavandero, S; Ocaranza, MP; Pinto, M; Ramirez, C; Roman, M; Varas, M1

Other Studies

1 other study(ies) available for angiotensin ii, des-phe(8)- and Ventricular Dysfunction

ArticleYear
Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 48, Issue:4

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Down-Regulation; Enalapril; Hemodynamics; Male; Myocardial Infarction; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction; Ventricular Function, Left

2006